Abcellera Biologics Inc. Stock
€2.34
Your prediction
Financial data and news for Abcellera Biologics Inc.
sharewise wants to provide you with the best news and tools for Abcellera Biologics Inc., so we directly link to the best financial data sources.
Financials
News
AbCellera Reports Q2 2024 Business Results
AbCellera (Nasdaq: ABCL) today announced financial results for the second quarter of 2024. All financial information in this press release is reported in U.S. dollars, unless otherwise indicated.
AbCellera and Lilly Expand Collaboration to Develop Antibody Medicines
AbCellera (Nasdaq: ABCL) announced today that it has expanded its existing collaboration with Eli Lilly and Company (Lilly) to discover therapeutic antibodies for programs in immunology
AbCellera to Report Second Quarter 2024 Financial Results on August 6, 2024
AbCellera (Nasdaq: ABCL) will announce its second quarter 2024 financial results on Tuesday, August 6, 2024, and hold an earnings conference call at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time)
AbCellera to Present at the Goldman Sachs 45th Annual Global Healthcare Conference on June 10, 2024
AbCellera (Nasdaq: ABCL) today announced that executives from the Company will present at the Goldman Sachs 45th Annual Global Healthcare Conference on Monday, June 10, 2024, at 12:20 p.m. Pacific
AbCellera Reports Q1 2024 Business Results
AbCellera (Nasdaq: ABCL) today announced financial results for the first quarter of 2024. All financial information in this press release is reported in U.S. dollars, unless otherwise indicated.
AbCellera, Viking Global Investors, and ArrowMark Partners Collaborate to Launch New Biotech Companies
AbCellera (Nasdaq: ABCL), Viking Global Investors (“Viking”), and ArrowMark Partners (“ArrowMark”) announced today that they have entered into a collaboration to advance new antibody drug programs
AbCellera Presents Data on T-Cell Engagers Against Four Tumor Targets at AACR 2024
AbCellera (Nasdaq: ABCL) today announced new data on its T-cell engager (TCE) programs at the American Association for Cancer ResearchⓇ (AACR) Annual Meeting 2024 at the San Diego Convention
AbCellera to Report First Quarter 2024 Financial Results on May 7, 2024
AbCellera (Nasdaq: ABCL) will announce its first quarter 2024 financial results on Tuesday, May 7, 2024, and hold an earnings conference call at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) the